ReviewMethodist DeBakey cardiovascular journal2021
Cardiovascular Disease Prevention During the COVID-19 Pandemic: Lessons Learned and Future Opportunities.
Review in Methodist DeBakey cardiovascular journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Influenza Vaccination for Cardiovascular Prevention: Further Insights from the IAMI Trial and an Updated Meta-analysis.Current cardiology reports · 2022Pooled it
- The collateral damage of COVID-19 to cardiovascular services: a meta-analysis.European heart journal · 2022Pooled it
- Mental Health Stressors of the COVID-19 Pandemic Negatively Affect Self-Management of Comorbid Cardiovascular Disease Among Persons Living With HIV in the United States: A Qualitative Study.The Journal of the Association of Nurses in AIDS Care : JANACTrial
- Out-of-Hospital Cardiac Arrest Before, During, and After the Pandemic of COVID-19.Journal of clinical medicine · 2026Article
- Web discussions on cardiovascular diseases: pre-COVID-19 evaluation and impact of the COVID-19 pandemic - Web listening analysis in the Italian population.BMC public health · 2024Article
- [Influence of the Corona pandemic on cardiovascular risk factors - Data from 1775 participants of the ELITE study before and during the Corona pandemic].Deutsche medizinische Wochenschrift (1946) · 2024Article
- Microvascular Capillary and Precapillary Cardiovascular Disturbances Strongly Interact to Severely Affect Tissue Perfusion and Mitochondrial Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Evolving from the Post COVID-19 Syndrome.Medicina (Kaunas, Lithuania) · 2024Article
- Pandemic-related practice changes and CVD risk management in community clinics.The American journal of managed care · 2024Article
- Health Care Access and Cardiovascular Risk Factor Management Among Working-Age US Adults During the Pandemic.Circulation. Cardiovascular quality and outcomes · 2023Article
- Acute SARS-CoV-2 Infection and Incidence and Outcomes of Out-of-Hospital Cardiac Arrest.JAMA network open · 2023Article
- Article
- Challenges in Caring for People with Cardiovascular Disease through and beyond the COVID-19 Pandemic: The Advantages of Universal Access to Home Telemonitoring.Healthcare (Basel, Switzerland) · 2023Article
- Control of Atherosclerotic Risk Factors During the COVID-19 Pandemic in the U.S.American journal of preventive medicine · 2023Article
- Polypharmacy Patterns in Multimorbid Older People with Cardiovascular Disease: Longitudinal Study.Geriatrics (Basel, Switzerland) · 2022Article
- Impact of COVID-19-related care disruptions on blood pressure management and control in community health centers.BMC public health · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The coronavirus disease 2019 (COVID-19) pandemic has been the defining healthcare issue since its outbreak, consuming healthcare systems and disrupting all aspects of human life throughout 2020 and continuing through 2021. When reviewing cardiovascular disease (CVD) prevention throughout the COVID-19 pandemic, the first tendency may be to focus on the negative disruption. Months of quarantine, isolation, and missed healthcare visits or delayed care may have exacerbated the epidemic of CVD in the United States. Looking back, however, perhaps it wasn't a lost year as much as a health crisis that better prepared us for the battle to improve cardiovascular health. The pandemic brought new platforms for interacting with patients eager to engage, presenting a unique opportunity to reset how we approach preventive care. In this review, we discuss what the pandemic has taught us about caring for those vulnerable patients who were most afflicted-older adults, persons of color, and people facing adverse socioeconomic circumstances-and who continue to be impacted by CVD. We also identify opportunities for enhanced CVD prevention now boosted by the overnight adoption of telemedicine and other innovative cardiac care models. Lastly, we discuss how the COVID-19 pandemic has motivated physicians and patients alike to prioritize our health above all else, if only transiently, and how we can leverage this increased health awareness and investment into long-term, meaningful disease prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.